ACE expression and Ang II levels were increased in DEN-injured rats, unraveling a role of ACE and Ang II as a mediator and therapeutic candidate target in liver disease progression and hepatocarcinogenesis (Figure 2, A and B). This evidence concerns the gene ACE and liver disorder.